PlainRecalls
LowClass IIIOngoing

FDA Drug recall · Reported June 3, 2026

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Recall #
D-0550-2026
Affected scope
59,808 pouches (4,272 Individual Folding Carton (IFC))
Initiated
May 14, 2026
Verify with FDA Drug →
View my saved recalls

Aveva Drug Delivery Systems, Inc. recalled Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGB… - a low-severity action.

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGB… was recalled by Aveva Drug Delivery Systems, Inc. in June 3, 2026. Reason: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shel…. Check the official notice for the remedy. Verify recall #D-0550-2026 with the FDA Drug before acting.

The recall

Aveva Drug Delivery Systems, Inc. issued this low-severity FDA Drug recall-Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shel….

Low
severity level
Class III
classification
June 3, 2026
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0550-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Household Products recalls over time

Where this recall sits in its category - 3,089 household products recalls on record

50100150200250 20052008201120142017202020232026 148
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.

Reason for recall

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Ongoing
Recall number D-0550-2026
Date reported June 3, 2026
Date initiated May 14, 2026
Recalling firm Aveva Drug Delivery Systems, Inc.
Firm location Miramar, FL
Affected scope 59,808 pouches (4,272 Individual Folding Carton (IFC))
Distribution Nationwide within the U.S

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0550-2026) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.. Recalled by Aveva Drug Delivery Systems, Inc.. Units affected: 59,808 pouches (4,272 Individual Folding Carton (IFC)).
Why was this product recalled?
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 3, 2026. Severity: Low. Recall number: D-0550-2026.
Where was the recalled product distributed?
Distribution: Nationwide within the U.S.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with CCM Hockey U.S. Recalls FMHVR Hybrid Visors and ACCHVR Repl… → · All Household Products recalls

This recall: FDA Drug, reported June 3, 2026. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026